The Chronic Lymphocytic Leukemia Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), AbbVie (Platinum), BeOne Medicines (Silver) and Lilly (Silver). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
VJVirtual | Latest updates in CLL from ERIC
Paolo Ghia, MD, PhD, Università Vita-Salute San Raffaele, Milan, Italy, shares an update on the latest news in chronic lymphocytic leukemia (CLL) from the European Research Initiative on CLL (ERIC). Dr Ghia highlights research investigating the relationship between COVID-19 and CLL as well as a study analyzing the occurrence of other malignancies in CLL and potential therapeutic causes. Finally, Dr Ghia discusses research investigating the optimal order in which to administer different types of therapy. This interview was recorded during an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).
